Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Haven't seen this partner before
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(118)
•••
Comment by Jonnyboy85on Mar 16, 2021 9:20pm
66 Views
Post# 32813847

RE:RE:RE:RE:Haven't seen this partner before

RE:RE:RE:RE:Haven't seen this partner beforeSorry Dimsmith, I'm a bad listener:)


Nailbiter1 wrote: Well dust me twice and fry me in maggoty butter.
Jonnyboy off the iggy for adding value to this board.
Choose shovel over sword... Always.
We are old enough not to be easily influenced by squish-heads like DJ superdolt-TNA and S.Gordon le crappeur.
Spend your time, don't waste it.
With this, a beer, a peck and three words to you buddy-boy.



Jonnyboy85 wrote: Well I figured that your team has the "temporary negative or positive opinions based on your latest open orders" category of posts covered so I would pick up the slack on DD:)


LithLover wrote: OMG Jonny adding some DD.


 

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities